Skip Header

Contribute Send feedback
Read comments (?) or add your own

P24530 (EDNRB_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Last modified January 25, 2012. Version 144. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (6) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Endothelin B receptor

Short name=ET-B
Short name=ET-BR
Alternative name(s):
Endothelin receptor non-selective type
Gene names
Name:EDNRB
Synonyms:ETRB
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length442 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is further processed into a mature form.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Non-specific receptor for endothelin 1, 2, and 3. Mediates its action by association with G proteins that activate a phosphatidylinositol-calcium second messenger system. Ref.8

Subcellular location

Cell membrane; Multi-pass membrane protein.

Tissue specificity

Expressed in placental stem villi vessels, but not in cultured placental villi smooth muscle cells. Ref.19

Post-translational modification

Palmitoylation of Cys-402 was confirmed by the palmitoylation of Cys-402 in a deletion mutant lacking both Cys-403 and Cys-405.

Involvement in disease

Defects in EDNRB are a cause of Waardenburg syndrome type 4A (WS4A) [MIM:277580]; also known as Waardenburg-Shah syndrome. WS4A is characterized by the association of Waardenburg features (depigmentation and deafness) and the absence of enteric ganglia in the distal part of the intestine (Hirschsprung disease). Ref.23 Ref.30

Defects in EDNRB are the cause of Hirschsprung disease type 2 (HSCR2) [MIM:600155]; also known as aganglionic megacolon (MGC). HSCR2 is a congenital disorder characterized by absence of enteric ganglia along a variable length of the intestine. It is the most common cause of congenital intestinal obstruction. Early symptoms range from complete acute neonatal obstruction, characterized by vomiting, abdominal distention and failure to pass stool, to chronic constipation in the older child. Ref.22 Ref.24 Ref.25 Ref.26 Ref.27 Ref.28

Defects in EDNRB are the cause of ABCD syndrome (ABCDS) [MIM:600501]. ABCD syndrome is an autosomal recessive syndrome characterized by albinism, black lock at temporal occipital region, bilateral deafness, aganglionosis of the large intestine and total absence of neurocytes and nerve fibers in the small intestine.

Sequence similarities

Belongs to the G-protein coupled receptor 1 family. Endothelin receptor subfamily. EDNRB sub-subfamily.

Sequence caution

The sequence BAD92435.1 differs from that shown. Reason: Erroneous initiation.

Ontologies

Keywords
   Cellular componentCell membrane
Membrane
   Coding sequence diversityAlternative splicing
Polymorphism
   DiseaseDeafness
Disease mutation
Hirschsprung disease
Waardenburg syndrome
   DomainSignal
Transmembrane
Transmembrane helix
   Molecular functionG-protein coupled receptor
Receptor
Transducer
   PTMDisulfide bond
Glycoprotein
Lipoprotein
Palmitate
   Technical termComplete proteome
Reference proteome
Gene Ontology (GO)
   Biological processactivation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger

Traceable author statement. Source: ProtInc

enteric nervous system development

Inferred from sequence or structural similarity. Source: BHF-UCL

enteric smooth muscle cell differentiation

Inferred from sequence or structural similarity. Source: BHF-UCL

macrophage chemotaxis

Inferred from mutant phenotype. Source: BHF-UCL

negative regulation of adenylate cyclase activity

Traceable author statement. Source: ProtInc

negative regulation of cellular protein metabolic process

Inferred from mutant phenotype. Source: BHF-UCL

negative regulation of neuron maturation

Inferred from sequence or structural similarity. Source: BHF-UCL

negative regulation of transcription from RNA polymerase II promoter

Inferred from mutant phenotype. Source: BHF-UCL

vein smooth muscle contraction

Inferred from mutant phenotype. Source: BHF-UCL

   Cellular componentintegral to plasma membrane

Traceable author statement. Source: ProtInc

   Molecular functionendothelin receptor activity

Inferred from direct assay Ref.3. Source: BHF-UCL

peptide hormone binding

Inferred from direct assay Ref.3. Source: BHF-UCL

Complete GO annotation...

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]
Isoform A (identifier: P24530-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform B (identifier: P24530-2)

The sequence of this isoform differs from the canonical sequence as follows:
     399-442: SCLCCWCQSF...FRSSNKYSSS → AGPHVGNKLV...MWPERKSNNN
Isoform C (identifier: P24530-3)

Also known as: Delta-3;

The sequence of this isoform differs from the canonical sequence as follows:
     1-1: M → MNKSTCLMAA...RTPSGAGSSM

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier
Sequence conflict79 – 846SGHRTP → RPPDA in AAD24541. Ref.10

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Signal peptide1 – 2626 Potential
Chain27 – 442416Endothelin B receptor
PRO_0000012729

Regions

Topological domain27 – 10175Extracellular Potential
Transmembrane102 – 12625Helical; Name=1; Potential
Topological domain127 – 13711Cytoplasmic Potential
Transmembrane138 – 16326Helical; Name=2; Potential
Topological domain164 – 17512Extracellular Potential
Transmembrane176 – 19722Helical; Name=3; Potential
Topological domain198 – 21821Cytoplasmic Potential
Transmembrane219 – 24325Helical; Name=4; Potential
Topological domain244 – 27128Extracellular Potential
Transmembrane272 – 29625Helical; Name=5; Potential
Topological domain297 – 32428Cytoplasmic Potential
Transmembrane325 – 35026Helical; Name=6; Potential
Topological domain351 – 36212Extracellular Potential
Transmembrane363 – 38927Helical; Name=7; Potential
Topological domain390 – 44253Cytoplasmic Potential

Amino acid modifications

Lipidation4021S-palmitoyl cysteine Ref.20
Lipidation4031S-palmitoyl cysteine Potential
Lipidation4051S-palmitoyl cysteine Potential
Glycosylation591N-linked (GlcNAc...) Potential
Disulfide bond174 ↔ 255 By similarity

Natural variations

Alternative sequence11M → MNKSTCLMAAETPSKRWRLH CLAFSQRFVRAGPACSSREA CSSPRAGWNPAGFRLPGRWS PFVALHLVCQIREALKLRSG HRTPSGAGSSM in isoform C.
VSP_001878
Alternative sequence399 – 44244SCLCC…KYSSS → AGPHVGNKLVMLFSVNIECD GTVNQNPTMWPERKSNNN in isoform B.
VSP_001879
Natural variant51P → T. Ref.14
Corresponds to variant rs12720160 [ dbSNP | Ensembl ].
VAR_019285
Natural variant71L → Q.
Corresponds to variant rs5345 [ dbSNP | Ensembl ].
VAR_014675
Natural variant171L → F.
Corresponds to variant rs5346 [ dbSNP | Ensembl ].
VAR_014676
Natural variant571G → S in HSCR2; sporadic; sex-dependent gene dosage effect; neuronal intestinal dysplasia; could be a polymorphism. Ref.25 Ref.26 Ref.27 Ref.28
Corresponds to variant rs1801710 [ dbSNP | Ensembl ].
VAR_003469
Natural variant761R → M.
Corresponds to variant rs2228271 [ dbSNP | Ensembl ].
VAR_024255
Natural variant1121F → V.
Corresponds to variant rs5347 [ dbSNP | Ensembl ].
VAR_014677
Natural variant1831A → G in WS4A. Ref.23
VAR_003470
Natural variant2441T → M.
Corresponds to variant rs5350 [ dbSNP | Ensembl ].
VAR_014678
Natural variant2761W → C in HSCR2. Ref.22
VAR_003471
Natural variant2921F → L in WS4A. Ref.30
VAR_015294
Natural variant3051S → N in HSCR2; familial. Ref.14 Ref.24
Corresponds to variant rs5352 [ dbSNP | Ensembl ].
VAR_003472
Natural variant3191R → W in HSCR2; sporadic. Ref.25 Ref.28
VAR_003473
Natural variant3741M → I in HSCR2. Ref.26
VAR_003474
Natural variant3831P → L in HSCR2; familial. Ref.25 Ref.28
VAR_003475

Experimental info

Mutagenesis4021C → S: Abolishes palmitoylation; when associated with S-403 and S-405. Ref.20
Mutagenesis4031C → S: Abolishes palmitoylation; when associated with S-402 and S-405. Ref.20
Mutagenesis4051C → S: Abolishes palmitoylation; when associated with S-402 and S-403. Ref.20
Sequence conflict101R → P in AAB19411. Ref.3
Sequence conflict161V → L Ref.8
Sequence conflict22 – 243SRI → LGV Ref.8
Sequence conflict351R → K Ref.8
Sequence conflict451I → M in BAD92435. Ref.12
Sequence conflict581S → P in BAF83388. Ref.13
Sequence conflict1401I → V Ref.8
Sequence conflict3851A → V in BAF83388. Ref.13

Sequences

Sequence LengthMass (Da)Tools
Isoform A [UniParc].

Last modified March 1, 1992. Version 1.
Checksum: CD4F96CF92C7C51E

FASTA44249,644
        10         20         30         40         50         60 
MQPPPSLCGR ALVALVLACG LSRIWGEERG FPPDRATPLL QTAEIMTPPT KTLWPKGSNA 

        70         80         90        100        110        120 
SLARSLAPAE VPKGDRTAGS PPRTISPPPC QGPIEIKETF KYINTVVSCL VFVLGIIGNS 

       130        140        150        160        170        180 
TLLRIIYKNK CMRNGPNILI ASLALGDLLH IVIDIPINVY KLLAEDWPFG AEMCKLVPFI 

       190        200        210        220        230        240 
QKASVGITVL SLCALSIDRY RAVASWSRIK GIGVPKWTAV EIVLIWVVSV VLAVPEAIGF 

       250        260        270        280        290        300 
DIITMDYKGS YLRICLLHPV QKTAFMQFYK TAKDWWLFSF YFCLPLAITA FFYTLMTCEM 

       310        320        330        340        350        360 
LRKKSGMQIA LNDHLKQRRE VAKTVFCLVL VFALCWLPLH LSRILKLTLY NQNDPNRCEL 

       370        380        390        400        410        420 
LSFLLVLDYI GINMASLNSC INPIALYLVS KRFKNCFKSC LCCWCQSFEE KQSLEEKQSC 

       430        440 
LKFKANDHGY DNFRSSNKYS SS 

« Hide

Isoform B [UniParc].

Checksum: A10BD0DD646F981E
Show »

FASTA43648,710
Isoform C (Delta-3) [UniParc].

Checksum: 9734B81C0064F533
Show »

FASTA53259,480

References

« Hide 'large scale' references
[1]"Cloning and sequence analysis of a cDNA encoding human non-selective type of endothelin receptor."
Nakamuta M., Takayanagi R., Sakai Y., Sakamoto S., Hagiwara H., Mizuno T., Saito Y., Hirose S., Yamamoto M., Nawata H.
Biochem. Biophys. Res. Commun. 177:34-39(1991) [PubMed: 1710450] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
[2]"Molecular cloning of a non-isopeptide-selective human endothelin receptor."
Ogawa Y., Nakao K., Arai H., Nakagawa O., Hosoda K., Suga S., Nakanishi S., Imura H.
Biochem. Biophys. Res. Commun. 178:248-255(1991) [PubMed: 1648908] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
[3]"Cloning and functional expression of human cDNA for the ETB endothelin receptor."
Sakamoto A., Yanagisawa M., Sakurai T., Takuwa Y., Yanagisawa H., Masaki T.
Biochem. Biophys. Res. Commun. 178:656-663(1991) [PubMed: 1713452] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
[4]"Molecular cloning of human endothelin (ET) receptors ETA and ETB."
Haendler B., Hechler U., Schleuning W.-D.
J. Cardiovasc. Pharmacol. 20:S1-S4(1992) [PubMed: 1282938] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
Tissue: Lung.
[5]"Molecular cloning of human endothelin receptors and their expression in vascular endothelial cells and smooth muscle cells."
Arai H., Nakao K., Hosoda K., Ogawa Y., Nakagawa O., Komatsu Y., Imura H.
Jpn. Circ. J. 56:1303-1307(1992) [PubMed: 1291713] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
[6]"The human endothelin-B receptor gene. Structural organization and chromosomal assignment."
Arai H., Nakao K., Takaya K., Hosoda K., Ogawa Y., Nakanishi S., Imura H.
J. Biol. Chem. 268:3463-3470(1993) [PubMed: 8429023] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA].
[7]"Molecular characterization and regulation of the human endothelin receptors."
Elshourbagy N.A., Korman D.R., Wu H.L., Sylvester D.R., Lee J.A., Nuthalaganti P., Bergsma D.J., Kumar C.S., Nambi P.
J. Biol. Chem. 268:3873-3879(1993) [PubMed: 8440682] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
[8]"Cloning and expression of an endothelin receptor subtype B from human prostate that mediates contraction."
Webb M.L., Chao C.-C., Rizzo M., Shapiro R.A., Neubauer M., Liu E.C.K., Aversa C.R., Brittain R.J., Treiger B.
Mol. Pharmacol. 47:730-737(1995) [PubMed: 7536888] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A), FUNCTION.
Tissue: Prostate.
[9]"Molecular characterization of a novel human endothelin receptor splice variant."
Elshourbagy N.A., Adamou J.E., Gagnon A.W., Wu H.L., Pullen M., Nambi P.
J. Biol. Chem. 271:25300-25307(1996) [PubMed: 8810293] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B).
Tissue: Placenta.
[10]"Novel endothelin B receptor transcripts with the potential of generating a new receptor."
Tsutsumi M., Liang G., Jones P.A.
Gene 228:43-49(1999) [PubMed: 10072757] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM C).
[11]"cDNA clones of human proteins involved in signal transduction sequenced by the Guthrie cDNA resource center (www.cdna.org)."
Warren C.N., Aronstam R.S., Sharma S.V.
Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
Tissue: Placenta.
[12]Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S., Ohara O., Nagase T., Kikuno R.F.
Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
Tissue: Brain.
[13]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Lung.
[14]NIEHS SNPs program
Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA], VARIANTS THR-5 AND ASN-305.
[15]"The DNA sequence and analysis of human chromosome 13."
Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L., Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S., Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P., Ambrose K.D., Andrews D.T. expand/collapse author list , Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P., Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C., Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P., Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L., Frankish A.G., Frankland J., French L., Garner P., Garnett J., Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M., Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D., Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D., Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S., Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S., Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S., Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R., Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P., Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R., Rogers J., Ross M.T.
Nature 428:522-528(2004) [PubMed: 15057823] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[16]Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. expand/collapse author list , Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W., Venter J.C.
Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[17]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM A).
Tissue: Skin.
[18]"Significance of novel endothelin-B receptor gene polymorphisms in Hirschsprung's disease: predominance of a novel variant (561C/T) in patients with co-existing Down's syndrome."
Zaahl M.G., du Plessis L., Warnich L., Kotze M.J., Moore S.W.
Mol. Cell. Probes 17:49-54(2003) [PubMed: 12628594] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-102; 172-196 AND 200-317.
[19]"Endothelin-1 and ETA receptor expression in vascular smooth muscle cells from human placenta: a new ETA receptor messenger ribonucleic acid is generated by alternative splicing of exon 3."
Bourgeois C., Robert B., Rebourcet R., Mondon F., Mignot T.-M., Duc-Goiran P., Ferre F.
J. Clin. Endocrinol. Metab. 82:3116-3123(1997) [PubMed: 9284755] [Abstract]
Cited for: TISSUE SPECIFICITY.
[20]"Palmitoylation of human endothelinB. Its critical role in G protein coupling and a differential requirement for the cytoplasmic tail by G protein subtypes."
Okamoto Y., Ninomiya H., Tanioka M., Sakamoto A., Miwa S., Masaki T.
J. Biol. Chem. 272:21589-21596(1997) [PubMed: 9261180] [Abstract]
Cited for: PALMITOYLATION AT CYS-402; CYS-403 AND CYS-405, MUTAGENESIS OF CYS-402; CYS-403 AND CYS-405.
[21]"Mutations in Hirschsprung disease: when does a mutation contribute to the phenotype."
Hofstra R.M.W., Osinga J., Buys C.H.C.M.
Eur. J. Hum. Genet. 5:180-185(1997) [PubMed: 9359036] [Abstract]
Cited for: REVIEW ON VARIANTS.
[22]"A missense mutation of the endothelin-B receptor gene in multigenic Hirschsprung's disease."
Puffenberger E.G., Hosoda K., Washington S.S., Nakao K., Dewit D., Yanagisawa M., Chakravarti A.
Cell 79:1257-1266(1994) [PubMed: 8001158] [Abstract]
Cited for: VARIANT HSCR2 CYS-276.
[23]"Mutation of the endothelin-receptor B gene in Waardenburg-Hirschsprung disease."
Attie T., Till M., Pelet A., Amiel J., Edery P., Boutrand L., Munnich A., Lyonnet S.
Hum. Mol. Genet. 4:2407-2409(1995) [PubMed: 8634719] [Abstract]
Cited for: VARIANT WS4A GLY-183.
[24]"Endothelin-B receptor mutations in patients with isolated Hirschsprung disease from a non-inbred population."
Auricchio A., Casari G., Staiano A., Ballabio A.
Hum. Mol. Genet. 5:351-354(1996) [PubMed: 8852659] [Abstract]
Cited for: VARIANT HSCR2 ASN-305.
[25]"Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease."
Amiel J., Attie T., Jan D., Pelet A., Edery P., Bidaud C., Lacombe D., Tam P., Simeoni J., Flori E., Nihoul-Fekete C., Munnich A., Lyonnet S.
Hum. Mol. Genet. 5:355-357(1996) [PubMed: 8852660] [Abstract]
Cited for: VARIANTS HSCR2 SER-57; TRP-319 AND LEU-383.
[26]"A homozygous mutation in the endothelin-3 gene associated with a combined Waardenburg type 2 and Hirschsprung phenotype (Shah-Waardenburg syndrome)."
Hofstra R.M.W., Tan-Sindhunata G., Wu Y., Kamsteeg E.-J., Stulp R.P., van Ravenswaaij-Arts C., Majoor-Krakauer D., Angrist M., Chakravarti A., Meijers C., Buys C.H.C.M.
Nat. Genet. 12:445-447(1996) [PubMed: 8630503] [Abstract]
Cited for: VARIANT HSCR2 ILE-374, VARIANT SER-57.
[27]"Phenotypic variation in a family with mutations in two Hirschsprung-related genes (RET and endothelin receptor B)."
Svensson P.J., Anvret M., Molander M.L., Nordenskjold A.
Hum. Genet. 103:145-148(1998) [PubMed: 9760196] [Abstract]
Cited for: VARIANT HSCR2 SER-57.
[28]"Functional characterization of three mutations of the endothelin B receptor gene in patients with Hirschsprung's disease: evidence for selective loss of Gi coupling."
Fuchs S., Amiel J., Claudel S., Lyonnet S., Corvol P., Pinet F.
Mol. Med. 7:115-124(2001) [PubMed: 11471546] [Abstract]
Cited for: CHARACTERIZATION OF VARIANTS HSCR2 SER-57; TRP-319 AND LEU-383.
[29]"ABCD syndrome is caused by a homozygous mutation in the EDNRB gene."
Verheij J.B., Kunze J., Osinga J., van Essen A.J., Hofstra R.M.
Am. J. Med. Genet. 108:223-225(2002) [PubMed: 11891690] [Abstract]
Cited for: INVOLVEMENT IN ABCD SYNDROME.
[30]"SOX10 mutations in chronic intestinal pseudo-obstruction suggest a complex physiopathological mechanism."
Pingault V., Girard M., Bondurand N., Dorkins H., Van Maldergem L., Mowat D., Shimotake T., Verma I., Baumann C., Goossens M.
Hum. Genet. 111:198-206(2002) [PubMed: 12189494] [Abstract]
Cited for: VARIANT WS4A LEU-292.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
M74921 mRNA. Translation: AAA58465.1.
D90402 mRNA. Translation: BAA14398.1.
S44866 mRNA. Translation: AAB19411.1.
S57283 mRNA. Translation: AAB25531.1.
D13168 Genomic DNA. Translation: BAA02445.1.
L06623 mRNA. Translation: AAA52342.1.
X99250 mRNA. Translation: CAA67623.1.
AF114165 mRNA. Translation: AAD24541.1.
AY275463 mRNA. Translation: AAP32295.1.
AB209198 mRNA. Translation: BAD92435.1. Different initiation.
AK290699 mRNA. Translation: BAF83388.1.
AY547312 Genomic DNA. Translation: AAS38516.1.
AL139002 Genomic DNA. Translation: CAM16893.1.
AL139002 Genomic DNA. Translation: CAH72430.1.
CH471093 Genomic DNA. Translation: EAW80573.1.
CH471093 Genomic DNA. Translation: EAW80575.1.
BC014472 mRNA. Translation: AAH14472.1.
AJ458188 Genomic DNA. Translation: CAD30645.1.
AJ458189 Genomic DNA. Translation: CAD30646.1.
AJ458190 Genomic DNA. Translation: CAD30647.1.
AJ458191 Genomic DNA. Translation: CAD30648.1.
IPIIPI00029123.
IPI00218197.
IPI00412464.
PIRJQ1042. A46609.
RefSeqNP_000106.1. NM_000115.3.
NP_001116131.1. NM_001122659.2.
NP_001188326.1. NM_001201397.1.
NP_003982.1. NM_003991.3.
UniGeneHs.82002.

3D structure databases

ProteinModelPortalP24530.
SMRP24530. Positions 102-410.
ModBaseSearch...

Protein-protein interaction databases

STRINGP24530.

Protein family/group databases

GPCRDBSearch...

PTM databases

PhosphoSiteP24530.

Polymorphism databases

DMDM119622.

Proteomic databases

PRIDEP24530.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENST00000334286; ENSP00000335311; ENSG00000136160.
ENST00000377211; ENSP00000366416; ENSG00000136160.
GeneID1910.
KEGGhsa:1910.
UCSCuc001vko.2. human.
uc010aez.1. human.

Organism-specific databases

CTD1910.
GeneCardsGC13M078469.
H-InvDBHIX0011385.
HGNCHGNC:3180. EDNRB.
HPACAB017842.
MIM131244. gene.
142623. phenotype.
277580. phenotype.
600155. phenotype.
600501. phenotype.
neXtProtNX_P24530.
Orphanet918. ABCD syndrome.
388. Hirschsprung disease.
897. Waardenburg-Shah syndrome.
PharmGKBPA27618.
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG07512.
GeneTreeENSGT00550000074261.
HOVERGENHBG051443.
InParanoidP24530.
OMAPVQKTAF.
OrthoDBEOG45HRX3.

Enzyme and pathway databases

Pathway_Interaction_DBarf6_traffickingpathway. Arf6 trafficking events.
endothelinpathway. Endothelins.
ReactomeREACT_111102. Signal Transduction.

Gene expression databases

ArrayExpressP24530.
BgeeP24530.
GenevestigatorP24530.
GermOnlineENSG00000136160. Homo sapiens.

Family and domain databases

InterProIPR000276. 7TM_GPCR_Rhodpsn.
IPR000499. Endthln_rcpt.
IPR001112. ETB_rcpt.
IPR017452. GPCR_Rhodpsn_supfam.
[Graphical view]
KOK04198.
PfamPF00001. 7tm_1. 1 hit.
[Graphical view]
PRINTSPR00571. ENDOTHELINBR.
PR00366. ENDOTHELINR.
PR00237. GPCRRHODOPSN.
PROSITEPS00237. G_PROTEIN_RECEP_F1_1. 1 hit.
PS50262. G_PROTEIN_RECEP_F1_2. 1 hit.
[Graphical view]
ProtoNetSearch...

Other

DrugBankDB00559. Bosentan.
NextBio7779.
SOURCESearch...

Entry information

Entry nameEDNRB_HUMAN
AccessionPrimary (citable) accession number: P24530
Secondary accession number(s): A2A2Z8 expand/collapse secondary AC list , A8K3T4, O15343, Q59GB1, Q5W0G9, Q8NHM6, Q8NHM7, Q8NHM8, Q8NHM9, Q9UD23, Q9UQK3
Entry history
Integrated into UniProtKB/Swiss-Prot: March 1, 1992
Last sequence update: March 1, 1992
Last modified: January 25, 2012
This is version 144 of the entry and version 1 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

7-transmembrane G-linked receptors

List of 7-transmembrane G-linked receptor entries

Human chromosome 13

Human chromosome 13: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families